Sun Pharma Acquisition of Organon Moves Forward Post Shareholder Approval

Sun Pharmaceutical Industries Limited announced that Organon & Co. stockholders have approved the merger transaction, a significant step towards Organon becoming a wholly owned subsidiary of Sun Pharma Holdings USA, Inc. This approval is a key milestone, though the acquisition is still contingent on satisfying remaining customary closing conditions, including regulatory approvals. Sun Pharma, a leading global pharmaceutical company, is a major player in India and holds strong positions in the US and emerging markets with a diverse portfolio including innovative medicines.